{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:28:12Z","timestamp":1790857692874,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.lpm.2007.01.012","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:54:08Z","timestamp":1201326848000},"page":"505-511","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Comment \u00e9valuer l'int\u00e9r\u00eat des\u00a0m\u00e9dicaments?"],"prefix":"10.1016","volume":"36","author":[{"given":"Jacques","family":"Massol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.01.012_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jbspin.2005.10.014","article-title":"Medical benefits from drugs","volume":"73","author":"Bouvenot","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2007.01.012_bib2","first-page":"1087","article-title":"Am\u00e9lioration du Service M\u00e9dical rendu","volume":"17","author":"Le Jeunne","year":"2003","journal-title":"Rev Prat Med Gen."},{"key":"10.1016\/j.lpm.2007.01.012_bib3","unstructured":"Code de S\u00e9curit\u00e9 Sociale. Articles R. 163-1 \u00e0 R 163-21."},{"key":"10.1016\/j.lpm.2007.01.012_bib4","first-page":"491","article-title":"Role of drugs in therapeutic strategies","volume":"52","author":"Castaigne","year":"2002","journal-title":"Rev Prat"},{"key":"10.1016\/j.lpm.2007.01.012_bib5","first-page":"941","article-title":"The transparency Commission: evaluation and reevaluation","volume":"30","author":"Bergmann","year":"2001","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2007.01.012_bib6","first-page":"307","article-title":"Drug evaluation in France: comparison of two approaches","volume":"56","author":"Dangoumau","year":"2001","journal-title":"Therapie"},{"key":"10.1016\/j.lpm.2007.01.012_bib7","first-page":"430","article-title":"What criteria for pharmaceuticals reimbursement? An empirical analysis of the evaluation of \"medical service rendered\" by reimbursable drugs in France","author":"Le Pen","year":"2003","journal-title":"Eur J Health Econ"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T07:53:47Z","timestamp":1546329227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0755498207000152"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.01.012","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}